Clinical Trial Update: Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B Patients

View source ↗

Summary

The document reports efficacy results from a trial of extended peginterferon alfa-2a treatment in HBeAg-negative chronic hepatitis B patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)

Snippet

Sponsor: Beijing Ditan Hospital | Conditions: Chronic Hepatitis B | Status: UNKNOWN